Research Article

Use of Self-Care and Practitioner-Based Forms of Complementary and Alternative Medicine before and after a Diagnosis of Breast Cancer

Table 6

Factors associated with starting (vs. continuing, stopping or never using) self-care and practitioner-based CAM after diagnosis among women in the LIBCSP, multivariable analyses, OR (95% Confidence Interval).

MultivitaminsbSingle vitamins/mineralsbBotanicalsbOther dietary supplementsbMind-bodybSpecial dietsbPrayerbSupport groupsbCAM practitionersb

Agea
 Continuous1.00 (0.97–1.03)1.01 (0.98–1.04)0.99 (0.95–1.04)0.99 (0.96–1.03)0.93 (0.89–0.97)1.01 (0.97–1.05)0.92 (0.87–0.98)0.96 (0.93–0.99)0.96 (0.93–0.99)
Racea
 Non-Hispanic white1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)
 All Other2.09 (0.98–4.46)1.37 (0.60–3.13)3.46 (1.33–9.01)0.76 (0.25–2.34)0.93 (0.31–2.79)3.63 (1.53–8.63)3.52 (1.02–12.10)0.87 (0.35–2.14)1.18 (0.48–2.87)
Annual household incomea
 <$25k1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)
 $25k–$49,9991.07 (0.52–2.17)1.30 (0.60–2.80)0.41 (0.14–1.23)0.93 (0.34–2.55)0.84 (0.25–2.91)1.17 (0.44–3.09)0.30 (0.06–1.39)1.39 (0.47–4.13)0.31 (0.13–0.72)
 $50k–$89,9990.90 (0.42–1.93)1.49 (0.66–3.36)0.47 (0.16–1.43)1.23 (0.43–3.53)0.71 (0.21–2.38)0.74 (0.26–2.10)0.39 (0.10–1.61)1.89 (0.64–5.55)0.39 (0.17–0.90)
 ≥$90k1.02 (0.44–2.36)2.00 (0.83–4.85)0.70 (0.22–2.30)1.41 (0.46–4.34)0.33 (0.09–1.25)0.75 (0.24–2.33)0.29 (0.06–1.47)1.75 (0.57–5.38)0.59 (0.24–1.46)
Educationa
 ≤High school grad.1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)
 Some college0.96 (0.57–1.62)1.03 (0.61–1.72)1.89 (0.91–3.95)1.64 (0.86–3.10)2.02 (0.98–4.17)1.13 (0.59–2.17)2.26 (0.80–6.37)1.24 (0.66–2.31)1.47 (0.80–2.68)
 College graduate0.82 (0.41–1.65)0.89 (0.44–1.78)0.82 (0.31–2.21)0.93 (0.39–2.25)1.76 (0.73–4.26)0.86 (0.36–2.07)0.87 (0.22–3.46)2.27 (1.13–4.56)1.05 (0.48–2.27)
 Postgraduate1.54 (0.84–2.82)0.97 (0.51–1.81)1.57 (0.66–3.72)1.36 (0.64–2.87)3.90 (1.76–8.62)0.87 (0.38–2.00)2.01 (0.59–6.80)1.75 (0.90–3.40)1.49 (0.75–2.96)
BMI at diagnosisa
 <251 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)
 25–291.01 (0.64–1.60)0.86 (0.54–1.38)1.02 (0.53–1.96)1.10 (0.63–1.93)1.27 (0.69–2.33)0.73 (0.41–1.28)0.38 (0.13–1.12)1.35 (0.82–2.23)1.07 (0.63–1.82)
 ≥301.05 (0.61–1.81)1.06 (0.61–1.85)1.54 (0.69–3.45)1.28 (0.64–2.57)2.11 (1.03–4.33)0.23 (0.08–0.64)1.31 (0.47–3.63)0.89 (0.46–1.74)1.30 (0.70–2.40)
Menopausal (meno.) statusa
 Premeno.1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)
 Postmeno.0.92 (0.50–1.68)0.83 (0.45–1.56)0.85 (0.38–1.87)1.12 (0.54–2.34)0.52 (0.24–1.10)0.84 (0.38–1.84)0.81 (0.26–2.47)1.20 (0.65–2.23)0.90 (0.47–1.75)
Mammograma
 Never/>5 yrs ago1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)
 <5 yrs ago1.06 (0.60–1.87)0.91 (0.52–1.62)1.07 (0.34–3.38)1.53 (0.48–4.86)1.20 (0.56–2.57)0.86 (0.42–1.73)1.70 (0.60–4.81)0.97 (0.52–1.78)1.66 (0.71–3.86)
Physical activity (h/wk)a
 01 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)
 0–0.690.70 (0.40–1.23)1.44 (0.82–2.51)1.03 (0.42–2.56)1.07 (0.54–2.15)1.39 (0.62–3.07)1.57 (0.70–3.52)0.47 (0.14–1.55)0.71 (0.35–1.42)0.89 (0.46–1.75)
 0.70–2.60.97 (0.57–1.66)1.16 (0.65–2.06)1.28 (0.56–2.92)0.57 (0.27–1.21)1.34 (0.62–2.90)1.99 (0.91–4.33)0.70 (0.24–1.99)1.22 (0.65–2.29)0.82 (0.43–1.57)
 ≥2.70.71 (0.40–1.27)0.85 (0.46–1.57)1.37 (0.60–3.10)1.06 (0.53–2.13)1.16 (0.52–2.59)1.81 (0.83–3.99)0.94 (0.33–2.68)0.90 (0.47–1.73)1.14 (0.60–2.15)
Cigarette smoking statusa
 Never1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)
 Current0.69 (0.39–1.22)0.81 (0.46–1.43)1.47 (0.66–3.31)0.72 (0.34–1.55)0.92 (0.45–1.88)0.77 (0.36–1.65)1.04 (0.39–2.72)0.72 (0.38–1.35)1.23 (0.67–2.28)
 Former0.83 (0.53–1.30)0.80 (0.51–1.26)1.32 (0.70–2.51)1.23 (0.72–2.09)0.93 (0.51–1.69)1.13 (0.63–2.00)0.49 (0.18–1.34)0.63 (0.38–1.05)1.12 (0.66–1.88)
Alcohol usea
 Never1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)
 Ever0.80 (0.52–1.22)0.85 (0.55–1.30)1.08 (0.57–2.03)1.13 (0.66–1.95)0.77 (0.44–1.35)0.88 (0.50–1.55)1.66 (0.68–4.07)1.11 (0.68–1.81)0.50 (0.31–0.81)
Fruit and vegetable intake (servings/wk)a
 0–341 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)
 ≥350.70 (0.46–1.08)0.77 (0.50–1.18)0.92 (0.51–1.64)1.04 (0.63–1.72)0.89 (0.51–1.54)0.93 (0.54–1.58)0.56 (0.23–1.35)1.20 (0.77–1.89)1.75 (1.10–2.78)
Stage at diagnosisa
 In situ1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)1 (Ref)
 Invasive0.85 (0.47–1.54)0.58 (0.32–1.06)0.96 (0.43–2.18)0.73 (0.37–1.45)0.84 (0.38–1.89)0.82 (0.39–1.71)0.51 (0.15–1.68)2.14 (0.99–4.64)1.02 (0.53–1.97)
Treatments receivedb
 Chemo. (no/yes)1.00 (0.62–1.60)1.12 (0.69–1.82)0.88 (0.45–1.74)0.58 (0.31–1.07)1.04 (0.55–1.99)1.08 (0.59–1.99)1.78 (0.65–4.93)1.24 (0.74–2.08)0.75 (0.43–1.29)
 Tamoxifen (no/yes)1.39 (0.89–2.17)1.86 (1.17–2.95)0.92 (0.50–1.68)1.54 (0.88–2.69)1.41 (0.79–2.52)0.69 (0.40–1.19)1.32 (0.57–3.06)1.17 (0.72–1.90)1.04 (0.64–1.70)
Continuous CAM Use before diagnosisb
 Multivit.N/A0.51 (0.33–0.77)1.23 (0.66–2.30)1.12 (0.66–1.91)0.57 (0.33–1.00)0.97 (0.56–1.67)0.59 (0.26–1.33)0.99 (0.61–1.60)0.85 (0.52–1.39)
 Single vit.0.52 (0.34–0.78)N/A9.92 (3.69–26.63)1.17 (0.68–2.01)1.49 (0.82–2.73)0.92 (0.52–1.62)0.63 (0.27–1.49)1.23 (0.73–2.05)0.93 (0.56–1.53)
 Botanicals1.13 (0.72–1.79)1.62 (1.02–2.57)N/A2.02 (1.20–3.41)1.98 (1.15–3.41)2.42 (1.41–4.15)1.65 (0.74–3.71)1.26 (0.79–2.00)1.49 (0.91–2.43)
 Other diet. supp.0.93 (0.44–1.94)0.39 (0.15–1.05)2.72 (1.39–5.33)N/A1.19 (0.55–2.58)1.04 (0.44–2.47)1.55 (0.48–5.03)1.72 (0.93–3.16)0.88 (0.41–1.90)
 Mind-body0.68 (0.36–1.26)0.88 (0.47–1.64)1.36 (0.69–2.68)1.69 (0.91–3.12)N/A0.58 (0.27–1.26)0.66 (0.21–2.04)2.39 (1.40–4.05)0.80 (0.42–1.53)
 Special diet0.69 (0.41–1.18)0.58 (0.33–1.00)1.09 (0.58–2.06)1.17 (0.66–2.07)1.12 (0.61–2.06)N/A0.95 (0.37–2.48)1.12 (0.67–1.86)0.63 (0.35–1.13)
 CAM practitioner0.93 (0.56–1.56)0.55 (0.31–0.97)0.93 (0.49–1.75)0.50 (0.26–0.96)1.13 (0.63–2.04)0.68 (0.35–1.33)1.00 (0.39–2.60)1.35 (0.82–2.23)N/A

Data collected at baseline, 1996-1997; bData collected at follow-up, 2002–2004.
Bold text indicates statistically significant odds ratio ( ).